As the Managed Health Care sector experiences a 5.23% gain, this analysis will spotlight on how specific tickers contributed to this uptrend over the last month. We’ll concentrate on $CI, $HUM, $MOH, $ELV, and $OSCR, diving into their performance and market behavior.
💼 Managed Health Care Sector: Elevate Your Trading Game with AI Robots! 💼
If you're keen on exploring the Managed Health Care group, we have the perfect tools to assist you in your trading journey. 🏥📈
🔄 "Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA)" is designed to help you navigate markets in decline. Whether you're a seasoned trader or just starting, this AI robot can provide valuable insights and strategies to thrive in challenging conditions.
⬆️ On the flip side, "Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA)" is your go-to companion when markets are on the rise. It offers a tailored approach to capitalize on upward trends and maximize your trading potential.
With these AI-powered tools at your disposal, you can confidently trade within the Managed Health Care sector, adapting to different market conditions and making informed decisions. Elevate your trading game and embark on a journey of trading excellence! 📊🚀
Tickers in this Group:
$CI - $HUM - $UNH - $MOH - $CNC - $CVS - $ELV - $OSCR - $ALHC
Description
Managed Health Care firms offer crucial health, medical, and disability plans aiming to streamline the cost of health care services. Major firms in this sector, including Aetna, Humana Inc., Cigna, UnitedHealthcare, provide insurance through various channels, ultimately aiming to make health care more accessible and affordable to the public.
Market Cap Analysis
With a group average market capitalization of $96.3B, the sector presents a diverse range of companies from $UNH at the pinnacle with $473B to $OSCR at $1.2B. This vast difference outlines the sector's diversity, offering traders various options to invest based on their market cap preference.
High and Low Price Notable News
The sector observed an average weekly growth of 0.45%, with a monthly enhancement of 5.77%. $ALHC leads the growth at 8%, while $ELV experienced a 1.53% decline. These fluctuations provide traders with insights into the tickers’ volatility and potential investment return.
Volume Insights
The sector’s stocks recorded an average weekly volume growth of -1.11%, with a significant decrease in the monthly and quarterly volume growth, which traders should consider when planning their investment strategies.
Fundamental Analysis Ratings
Ticker Spotlight: $CI, $HUM, $MOH, $ELV, $OSCR
$CI - Cigna Group (The)
$CI has shown a promising upward trend with its 10-day moving average crossing above its 50-day counterpart, signaling a potential buying opportunity with an 86% chance of continued growth.
$HUM - Humana
With its price surging above the 50-day moving average, $HUM indicates a strong upward trend, providing traders an 80% likelihood of further price increase in the upcoming month.
$MOH - Molina Healthcare
$MOH broke its lower Bollinger Band, suggesting a potential rise back towards the middle band. With an 81% chance of upward movement, this ticker presents a promising buy for traders.
$ELV - Elevance Health
$ELV is expected to rebound from its lower Bollinger Band, offering traders a probable 78% chance of engaging in a continued uptrend in the next month.
$OSCR - Oscar Health
Breaking its lower Bollinger Band, $OSCR provides traders with a compelling buy option, boasting an 83% probability of sustaining its upward trend.
With the Managed Health Care sector experiencing a +5.23% gain, tickers like $CI, $HUM, $MOH, $ELV, and $OSCR are at the forefront of this positive movement. As traders, understanding the nuances of each ticker’s performance, market cap, and volume growth is crucial for making informed investment decisions in this thriving sector.
On December 24, 2024, the Stochastic Oscillator for CI moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 60 instances where the indicator left the oversold zone. In of the 60 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
The Moving Average Convergence Divergence (MACD) for CI just turned positive on January 02, 2025. Looking at past instances where CI's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CI advanced for three days, in of 345 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CI as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CI entered a downward trend on December 27, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.234) is normal, around the industry mean (3.063). P/E Ratio (20.936) is within average values for comparable stocks, (17.509). Projected Growth (PEG Ratio) (0.928) is also within normal values, averaging (1.089). Dividend Yield (0.014) settles around the average of (0.020) among similar stocks. P/S Ratio (0.554) is also within normal values, averaging (0.684).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of life, hospital and medical insurance plans
Industry ManagedHealthCare